Last checked at 
LONDON (Alliance News) - First Derivatives PLC on Friday said Chief Executive Officer Brian Conlon has recently been diagnosed with cancer and will remain as CEO during his treatment.
The trading software developer said Conlon will receive ongoing weekly treatment which will include chemotherapy. The treatment is likely to last for a number of months.
First Derivatives Chair Seamus Keating said: "The board has set a clear strategy and the executive committee, led by Brian, has delivered strong execution of that strategy year-on-year. During the period of his treatment I will provide additional executive and governance support and I am confident that Brian and his team will continue to execute the group's growth plans successfully."
Shares in First Derivatives were down 1.1% at 3,065.00 pence on Friday morning.
